AMY FORREST: Open Payments
NPI 1043326986 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$121 in 6 payments from 4 companies in 2025. Trend: 2023 $121 · 2024 $271 · 2025 $121
Food & beverage: $121
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $21 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: BREZTRI, MYFEMBREE, Wegovy, FARXIGA, Veozah.
Industry payments across MS — which companies pay providers there.
